Evidence map›Paper›PMID 37198379›Full record

Trial reportEndocrine2023

Predicting the HbA

Lea Bruhn, Dorte Vistisen, Hanan Amadid, Kim K B Clemmensen, Kristian Karstoft, Mathias Ried-Larsen, Frederik Persson, Marit E Jørgensen, Cathrine Laustrup Møller, Bente Stallknecht and 2 more

Open access · greenAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Endocrine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lea BruhnSteno Diabetes Center Copenhagen, Herlev, Denmark.
Dorte VistisenSteno Diabetes Center Copenhagen, Herlev, Denmark.
Hanan AmadidSteno Diabetes Center Copenhagen, Herlev, Denmark.
Kim K B ClemmensenSteno Diabetes Center Copenhagen, Herlev, Denmark.
Kristian KarstoftThe Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Mathias Ried-LarsenThe Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Frederik PerssonSteno Diabetes Center Copenhagen, Herlev, Denmark.
Marit E JørgensenSteno Diabetes Center Copenhagen, Herlev, Denmark.
Cathrine Laustrup MøllerNovo Nordisk A/S, Måløv, Denmark.
Bente StallknechtDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Kristine FærchSteno Diabetes Center Copenhagen, Herlev, Denmark.
Martin B BlondSteno Diabetes Center Copenhagen, Herlev, Denmark. martin.baek.blond@regionh.dk.ORCID 0000-0002-2032-1560
Steno Diabetes Centers · DKUniversity of Copenhagen · DKNovo Nordisk (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate whether the prediction of post-treatment HbA

methodsWe performed an exploratory analysis based on data from 112 individuals with prediabetes (HbA

resultsThe prediction models explained 46-50% of the variation (R

conclusionAdding an additional biomarker of the glucose metabolism did not improve the prediction of post-treatment HbA

Indexed as

Diabetes Mellitus, Type 2InsulinsPrediabetic StateBiomarkersBlood GlucoseGlucoseGlycated HemoglobinHumansBiomarkersBlood GlucoseGlucoseGlycated HemoglobinInsulinsGlycemiaHbA1cPrediabetesPredictionStratified medicineTreatment response

Identifiers

PMID37198379
OpenAlexW4376868145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.